View Older Stories View More Recent Stories

Sep 8, 2022 10:00AM Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health Applications
Sep 7, 2022 12:00PM Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022
Sep 6, 2022 08:07AM Applied DNA Sciences (APDN) Launches Monkeypox Testing Service
Sep 6, 2022 08:00AM Applied DNA Launches Monkeypox Testing Service
Aug 19, 2022 09:45AM Applied DNA Sciences (APDN) Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
Aug 19, 2022 09:45AM Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health
Aug 11, 2022 04:10PM Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
Aug 10, 2022 09:32AM Applied DNA Sciences (APDN) Subsidiary Reports LinearDNA Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles
Aug 10, 2022 09:30AM Applied DNA Biotherapeutics Subsidiary Reports LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)
Aug 9, 2022 11:30AM Applied DNA Sciences (APDN) Awarded Extension of Health Services Contract with The City University of New York
Aug 9, 2022 11:30AM Applied DNA Awarded Extension of Health Services Contract with The City University of New York 
Aug 9, 2022 08:15AM Applied DNA Sciences (APDN) Receives $3.6M in Net Proceeds from Warrant Exercise
Aug 9, 2022 08:15AM Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise
Aug 8, 2022 04:05PM Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates
Aug 8, 2022 01:15PM Applied DNA Announces Closing of Upsized $12 Million Public Offering
Aug 4, 2022 09:24AM Applied DNA Sciences (APDN) Prices $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules
Aug 4, 2022 09:16AM Applied DNA Announces Pricing of $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules
Aug 2, 2022 08:48AM Applied DNA Sciences (APDN) Initiates Analytical Validation of PCR-based Diagnostic Test Specific to Monkeypox Virus
Aug 2, 2022 08:03AM Applied DNA Initiates Analytical Validation of PCR-based Diagnostic Test Specific to Monkeypox Virus
Jul 25, 2022 08:33AM Applied DNA's (APDN) LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA
Jul 25, 2022 08:30AM Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Deve
Jul 22, 2022 10:00AM Applied DNA's (APDN) LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
Jul 22, 2022 10:00AM Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA
Jun 29, 2022 10:00AM Applied DNA Launches Initiatives to Expand Awareness of LinearDNA™ Platform as an Alternative to Plasmid DNA for Therapeutic Applications, Revamps LineaRx Website  
Jun 21, 2022 09:18AM U.S. Government Guidance Permits DNA Traceability and Isotopic Testing as Evidence under Uyghur Forced Labor Prevention Act
Jun 6, 2022 11:30AM Applied DNA Sciences (APDN), EvviVax Announce Peer-Reviewed Publication of Positive Preclinical Data for LinearDNA Platform as a Novel Cancer Vaccine Strategy in the Journal of Experimental & Clinical
Jun 6, 2022 11:30AM Applied DNA and EvviVax Announce Peer-Reviewed Publication of Positive Preclinical Data for LinearDNA™ Platform as a Novel Cancer Vaccine Strategy in the Journal of Experimental & Clinical Cance
May 12, 2022 04:05PM Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 9, 2022 10:00AM Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
Apr 6, 2022 09:00AM Applied DNA Awarded NYC-Based ‘Return-to-Office’
Mar 23, 2022 12:00PM Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
Mar 14, 2022 08:08AM Applied DNA Sciences (APDN) Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
Mar 14, 2022 08:00AM Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
Mar 10, 2022 10:00AM Applied DNA to Participate in Fireside Chat at the 34th Annual ROTH Investor Conference
Feb 24, 2022 05:50PM Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
Feb 22, 2022 08:05AM Applied DNA Sciences (APDN) Prices 1.5M Share Direct Offering at $2.80/sh
Feb 22, 2022 08:00AM Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
Feb 10, 2022 04:05PM Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
Feb 3, 2022 10:00AM Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
Jan 28, 2022 11:10AM Applied DNA Sciences (APDN) to Deploy Linea 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
Jan 28, 2022 11:10AM Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
Jan 21, 2022 10:02AM Applied DNA Sciences (APDN) Submits Request for EUA to FDA for Linea 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
Jan 21, 2022 10:00AM Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
Jan 18, 2022 09:08AM Applied DNA Sciences (APDN) Announces Continued Momentum in COVID-19 Testing Demand
Jan 18, 2022 09:00AM Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
Jan 4, 2022 08:09AM Applied DNA Sciences (APDN) Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
Jan 4, 2022 08:00AM Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
Dec 15, 2021 09:00AM Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
Dec 9, 2021 04:05PM Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing
Dec 6, 2021 09:00AM Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
View More Recent Stories View Older Stories